Cancer expertise at Leicester enhanced with new appointments

Posted by pt91 at May 21, 2012 04:55 PM |
Quartet of knowledgeable specialists appointed to cancer research positions.
Cancer expertise at Leicester enhanced with new appointments

Cancer cell (image: GENIE)

The University of Leicester has invested in cutting edge cancer expertise through a series of new appointments to its cancer research programme.

The four cancer specialists support the University's status as a major centre of cancer studies within the UK and the foremost centre in the East Midlands. It follows the recent announcement of renewed funding for our Experimental Cancer Medicine Centre.

Professor Catrin Pritchard has taken up the reins as head of the Cancer Theme, a multi-disciplinary research programme consisting of 52 academic staff across the Departments of Biochemistry, Cancer Studies and Molecular Medicine, Cell Physiology and Pharmacology, Chemistry and Genetics and also colleagues within the MRC Toxicology Unit and the NHS.

 Catrin Pritchard
 Dean Fennell

Leading lung cancer oncologist at the Queen's University of Belfast and former CRUK clinical research fellow Professor Dean Fennell was recruited to spearhead the University's lung cancer initiative. The post will see him work with the Department of Cancer Studies and Molecular Medicine as well as the respiratory and lung cancer teams at Glenfield and the Commercial Trials Unit at the Leicester Royal Infirmary.

Dr Richard Bayliss is a molecular biologist who will lead a team of researchers investigating the structures of cell proteins in order to better understand the process of uncontrolled cell division, which causes tumours to grow.

Richard Bayliss
 Karen Brown

Chemoprevention specialist Karen Brown has been promoted to Professor, with increased responsibilities in the Cancer Biomarkers and Prevention Group. Professor Brown is Joint Principal Investigator of the Experimental Cancer Medicine Centre, and works to find agents that can stop the onset of cancer and reduce the need for chemotherapy – particularly compounds found in the diet.